In IBD patients, NF-κB is activated and the increased expression of NF-κB in mucosal macrophages is accompanied by an increased ability of these cells to produce and secrete TNF-α, IL-1, and IL-6, thereby promoting the expression of various proinflammatory genes and influencing the process of mucosal inflammation (71). This evidence concerns the gene IL1B and inflammatory bowel disease.